Back to Journals » OncoTargets and Therapy » Volume 11

Risk of bleeding associated with antiangiogenic monoclonal antibodies bevacizumab and ramucirumab: a meta-analysis of 85 randomized controlled trials

Total article views   HTML views PDF downloads Totals
11,436 Dovepress* 9,413+ 853 10,266
PubMed Central* 2,023 477 2,500
Totals 11,436 1,330 12,766
*Since 21 August 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar